Review articlePramlintide in the treatment of type 1 and type 2 diabetes mellitus
References (40)
- et al.
Amylin concentrations and glucose control
Lancet
(1992) - et al.
In vitro autoradiographic localization of amylin binding sites in rat brain
Neuroscience
(1994) - et al.
The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus
Metabolism
(1999) - et al.
Effect of pramlintide on A1C and bodyweight in insulin-treated African Americans and Hispanics with type 2 diabetes: A pooled post hoc analysis
Metabolism
(2003) - et al.
Projection of diabetes burden through 2050: The impact of changing demography and disease prevalence in the US
Diabetes Care
(2001) - et al.
Cost-of-illness studies in diabetes mellitus
Pharmacoeconomics
(2004) Diagnosis and classification of diabetes mellitus
Diabetes Care
(2005)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
N Engl J Med
(1993)Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
Lancet
(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33)
Lancet
(1998)
Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
JAMA
(2004)
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
High affinity amylin binding sites in rat brain
Mol Pharmacol
(1993)
Prolactin-releasing peptide affects gastric motor function in rat by modulating synaptic transmission in the dorsal vagal complex
J Physiol
(2004)
The anorectic effect of a chronic peripheral infusion of amylin is abol ished in area postrema/nucleus of solitary tract (AP/NTS) lesioned rats
Int J Obes Relat Metab Disord
(2001)
Coexpression of receptors for adrenomedullin, calcitonin gene related peptide, and amylin in pancreatic beta-cells
Endocrinologl
(2000)
Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: A physiological approach toward improved metabolic control
Curr Pharm Des
(2001)
Molecular physiology of amylin
J Cell Biochem
(1994)
The human amylin analog, pramlintide, reduces postprandial hyper glucagonemia in patients with type 2 diabetes mellitus
Horm Metab Res
(2002)
Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM
Diabetologia
(1997)
Cited by (0)
Copyright © 2005 Published by Elsevier Inc.